PROSHARES TR - SHRT HGH YIELD (SJB)

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / SHRT HGH YIELD
Total 13F shares
2,219,222
Share change
+1,894,012
Total reported value
$40,241,533
Put/Call ratio
0.35%
Price per share
$18.10
Number of holders
31
Value change
+$34,286,168
Number of buys
24
Number of sells
5

Institutional Holders of PROSHARES TR - SHRT HGH YIELD (SJB) as of Q1 2022

As of 31 Mar 2022, PROSHARES TR - SHRT HGH YIELD (SJB) was held by 31 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,219,222 shares. The largest 10 holders included REUTER JAMES WEALTH MANAGEMENT, LLC, Csenge Advisory Group, JANE STREET GROUP, LLC, Stratos Wealth Advisors, LLC, Cavalier Investments, LLC, FLOW TRADERS U.S. LLC, Maltin Wealth Management, Inc., TD Waterhouse Canada Inc., Jefferies Group LLC, and NewEdge Advisors, LLC. This page lists 31 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.